Cargando…
The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation
Osteoporosis is caused by an imbalance between bone formation and bone resorption. Receptor activator of nuclear factor-κB ligand (RANKL) promotes the activity and differentiation of osteoclasts via activating the nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathwa...
Autores principales: | Chen, Wenxiang, Xie, Ziang, Tang, Pan, Wang, Yongli, Jie, Zhiwei, Qin, An, Jiang, Xuesheng, Hu, Zhijun, Fan, Shunwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737093/ https://www.ncbi.nlm.nih.gov/pubmed/31506437 http://dx.doi.org/10.1038/s41419-019-1914-5 |
Ejemplares similares
-
Lumican Inhibits Osteoclastogenesis and Bone Resorption by Suppressing Akt Activity
por: Lee, Jin-Young, et al.
Publicado: (2021) -
Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice
por: Huang, Bao, et al.
Publicado: (2019) -
Regulation of Osteoclastogenesis and Bone Resorption by miRNAs
por: Inoue, Kazuki, et al.
Publicado: (2021) -
The novel NF-κB inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia
por: Kanduri, M, et al.
Publicado: (2011) -
Studies on the treatment of melanoma with folate acid conjugated dextran and lauryl alcohol loaded with IMD0354
por: Liu, Can, et al.
Publicado: (2019)